Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: gac  suv  gs7  car  auto  china  commercial  style  multivu  8166551  bloodcenter  health  healthcare  thrombocytopenia  blood  treatment  multivu  8126851  sickle  cell  disease  health  wellness  treatment  medical  hospital  scd  research  multivu  7903251  medical  health  research  gene  therapy  scid  treatment  st  jude  children  research  hospital  multivu  7808651  asuragen  fragilex  syndromes  autism  xpansion  interpreter  genetic  test  pregnancy  children  women  health  multivu  60719  sell  house  fast  foreclosure  preforeclosure  job  transfer  behind  mortgage  payments  inherited  property  divorce  sick  tenants  gene  therapy  hemophilia  b  bleeding  disorder  st  jude  childrens  research  hospital  university  college  london  multivu  46766 
Search // inherited
Results 1-7 of 7 for ' inherited ' (1 seconds)
China’s fastest-growing automaker, GAC Motor, has released two new SUVs onto the market, the 5-seat GS7 and the entry SUV GS3 in watertown Wuzhen, Zhejiang Province, China where tradition embraces innovation. These two next-generation SUVs, which have inherited the excellent genes of the GAC Motor family, are poised to bolster the company’s already astounding growth and drive its plans for global expansion. GAC Motor chose Wuzhen as the place to begin its redefinition of SUVs for young consumers because of the water town’s rich history, its status as a hotbed for high-tech and innovation, and because of its youthful, fashionable and forward-thinking vibes, which is in line with the targeted young consumers of the two new models. Since 2014, Wuzhen has been the home for the World Internet Conference, which attracts prominent internet figures from 120 countries. To view the multimedia release go to: https://www.multivu.com/players/English/8166551-gac-motor-gs7-gs3-launch/
Tags // gac  suv  gs7  car  auto  china  commercial  style  multivu  8166551 
Categories // Miscellaneous 
Added: 2404 days ago by MultiVuVideos
Runtime: 0m30s | Views: 541 | Comments: 1
Not yet rated
 

 

 

BloodCenter of Wisconsin’s Diagnostic Laboratories, part of Versiti, today announced the launch of seven hematology genetics test panels. The new test panels enhance and expand BloodCenter’s genetic testing capability to include a vast array of non-malignant hematology disorders, including platelet function disorders, inherited thrombocytopenia and congenital neutropenias, providing one of the most comprehensive test menus in hematology. BloodCenter’s integration of functional and genetic testing provides a unique approach to diagnosing complex hematology disorders, providing a comprehensive review of each patient for improved patient care and outcomes. To view the multimedia release go to: https://www.multivu.com/players/English/8126851-bloodcenter-of-wisconsin-versiti-hematology-genetics-test-panels/
Categories // Miscellaneous 
Added: 2467 days ago by MultiVuVideos
Runtime: 1m57s | Views: 484 | Comments: 1
Not yet rated
 

 

 

Sickle cell disease (SCD) is an inherited, lifelong chronic disorder affecting nearly 100,000 Americans and a growing global health problem that will touch nearly 30 percent more people globally in the next three decades. Though new approaches to managing SCD have led to improvements in diagnosis and supportive care, people living with the disease still have severe complications to overcome. Many are unable to access quality care and are limited by a lack of effective treatment options. In an effort to identify unmet medical needs for people with SCD, the American Society of Hematology (ASH), along with other groups, issued the State of Sickle Cell Disease: 2016 Report, evaluating the disease in four priority areas — access to care, training and professional education, research and clinical trials, and global health. The report shows that significant improvements are needed across all areas and that, though patients are living longer, the system of care needs to change to ensure a better quality of life. To address these challenges, ASH launched the Sickle Cell Disease Coalition along with more than 20 other organizations who are issuing a call to action that will amplify the voice of the SCD community, promote SCD awareness, and transform SCD care both in the United States and around the globe. To view the multimedia release go to: http://www.multivu.com/players/English/7903251-american-society-hematology-sickle-cell-coalition/
Categories // Miscellaneous 
Added: 2760 days ago by MultiVuVideos
Runtime: 2m49s | Views: 537 | Comments: 0
Not yet rated
 

 

 

Adolescents and young adults with a severe inherited immunodeficiency disorder improved following treatment with novel gene therapy developed at St. Jude Children’s Research Hospital and at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The results of this study appear today in the journal Science Translational Medicine. The study involved five males with X-linked severe combined immunodeficiency disease (SCID-X1), also known as “Bubble Boy” disease, who were all treated at NIAID. This inherited disorder involves a mutation in the IL2RG gene that affects males and occurs in 1 of every 50,000 to 100,000 live births, leaving them with little to no immune protection. To view the multimedia release go to: http://www.multivu.com/players/English/7808651-st-jude-gene-therapy-results/
Categories // Miscellaneous 
Added: 2898 days ago by MultiVuVideos
Runtime: 1m41s | Views: 561 | Comments: 0
Not yet rated
 

 

 

Asuragen Inc., a leading molecular diagnostics company, today announced results from a study demonstrating that a new molecular test called Xpansion Interpreter® can improve the determination of a woman’s risk of having a child with fragile X syndrome, the most common inherited cause of intellectual disability and autism, compared to existing risk measures. The Xpansion Interpreter Test is based on a technology breakthrough that reveals both the number and position of “interrupting” DNA sequences in the fragile X gene of the mother and more accurately estimates the likelihood that her child will have fragile X syndrome. The study will be published in the April issue of the American Journal of Medical Genetics and presented today at the 2013 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting in Phoenix, AZ. To view Multimedia News Release, go to http://www.multivu.com/mnr/60719-asuragen-xpansion-interpreter-xi-test-data-fragile-x-syndrome-autism
Added: 4025 days ago by MultiVuVideos
Runtime: 3m22s | Views: 1855 | Comments: 0
Not yet rated
 

 

 

Do you need to sell your home? Fast? Need Cash? Ace Real Estate Group is your solution. Website: www.AceRealEstateSolutions.com We will buy your problem property and resolve your situation. -Behind on payments -Sick of tenants -Divorce -Unwanted inheritance -Job transfer
Categories // People and Blog 
Added: 4053 days ago by taton
Runtime: 0m29s | Views: 3576 | Comments: 0
Not yet rated
 

 

 

Symptoms improved significantly in adults with the bleeding disorder hemophilia B following a single treatment with gene therapy developed by researchers at St. Jude Children’s Research Hospital in Memphis and demonstrated to be safe in a clinical trial conducted at the University College London (UCL) in the U.K. The findings of the six-person study mark the first proof that gene therapy can reduce disabling, painful bleeding episodes in patients with the inherited blood disorder. Results of the Phase I study appear in the December 10 online edition of the New England Journal of Medicine. The research is also scheduled to be presented December 11 at the 53rd annual meeting of the American Society of Hematology in San Diego. To view Multimedia News Release, go to http://www.multivu.com/mnr/46766-st-jude-children-s-research-hospital-gene-therapy-bleeding-disorder
Categories // Science and Technology 
Added: 4488 days ago by MultiVuVideos
Runtime: 4m58s | Views: 4168 | Comments: 0
Not yet rated
 

 

 

Page 1 of 1  |  Go to page   



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2024 ClipMoon.com. All rights reserved.